Ethyl-2-(3-cyano-4-isobutoxyphenyl)-4-methylthiazol-5-carboxylate

Ethyl-2-(3-cyano-4-isobutoxyphenyl)-4-methylthiazol-5-carboxylate
Product Description

Advance Intermediates for Febuxostat

CHEMCO INNOVATIVE CHEMIE PRIVATE LIMITED

  • Country/Region:
    India
  • Founded:
    1976
  • On CPHI since:
    2024
  • Certificates:
    2
  • Employees:
    100 - 249
Company types
CMO/CDMO
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Chemical Development
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Fine Chemicals Company
Intermediates Manufacturer
Specifications
  • CAS Registry Number
    160844-75-7
  • Details
    Rheumatology
  • Selling Points
    Ethical Sourcing; Green Product; International Approvals/Standards; Quality Service; Reputation; -
  • Model
    -
  • Supplied from
    India
  • Measured In
    kilogram

CHEMCO INNOVATIVE CHEMIE PRIVATE LIMITED

  • Country/Region:
    India
  • Founded:
    1976
  • On CPHI since:
    2024
  • Certificates:
    2
  • Employees:
    100 - 249
Company types
CMO/CDMO
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Chemical Development
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Fine Chemicals Company
Intermediates Manufacturer

More Products from CHEMCO INNOVATIVE CHEMIE PRIVATE LIMITED (26)

CHEMCO INNOVATIVE CHEMIE PRIVATE LIMITED resources (5)

  • News Upcoming GMP Unit for Advanced Intermediates

    Chemco is expanding its pharmaceutical manufacturing capabilities through an upcoming GMP unit dedicated to advanced and penultimate intermediates. The facility is being developed to support customer programs linked to APIs including Acalabrutinib, Ambrisentan, Apixaban, Apremilast, Canagliflozin, Chlorthalidone, Dapagliflozin, Sotagliflozin, Doxofylline, Empagliflozin, Etoricoxib, Famotidine, Ibrutinib, Mirabegron, Tazemetostat, Ticagrelor and Praziquantel.

    The new unit will support process development, technology transfer, scale-up and commercial manufacturing, with a focus on reliable execution, long-term supply and customer-specific intermediate programs.

  • Brochure Keynote 2025/26

    We are thrilled to share our Keynote 2025/26 address by Mr. Samir Mody, Director of Chemco Group. He highlights our journey of innovation, recent advancements i
  • Brochure Chemco 2026 Brochure

    Established in 1976, Chemco is an Indian manufacturer with deep expertise in nitration and specialty chemistry. We are now advancing into KSMs, advanced and penultimate pharmaceutical intermediates, supporting customers from development and technology transfer through scale-up and long-term commercial manufacturing.

    Upcoming GMP Unit - December 2026. 
  • Whitepaper Product List

    Please find our product list here.